Legend Financial Advisors’s DiaMedica Therapeutics DMAC Stock Holding History

Legend Financial Advisors’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$3.9K	–	70
2025 Q2	$3.9K	Buy	+1,000	New	+$3.9K	﹤0.01%	144
2025 Q1	–	Sell	-1,000	Closed	-$5.43K	–	93
2024 Q4	$5.43K	Hold	1,000	–	–	﹤0.01%	150
2024 Q3	$4.19K	Hold	1,000	–	–	﹤0.01%	133
2024 Q2	$2.95K	Hold	1,000	–	–	﹤0.01%	214
2024 Q1	$2.77K	Hold	1,000	–	–	﹤0.01%	171
2023 Q4	$2.84K	Hold	1,000	–	–	﹤0.01%	171
2023 Q3	$2.58K	Hold	1,000	–	–	﹤0.01%	176
2023 Q2	$4.32K	Hold	1,000	–	–	﹤0.01%	184
2023 Q1	$1.53K	Hold	1,000	–	–	﹤0.01%	215
2022 Q4	$1.58K	Hold	1,000	–	–	﹤0.01%	226
2022 Q3	$1.24K	Buy	+1,000	New	+$1.56K	﹤0.01%	217

Other funds holding DMAC

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Legend Financial Advisors's DMAC Position: Q3 2025 in Review

Legend Financial Advisors sold out of DiaMedica Therapeutics (DMAC) in Q3 2025, closing a stake of 1,000 shares — an estimated $3.9K sold.

Legend Financial Advisors first reported a position in DMAC in Q3 2022 and held it in 11 quarters. The position peaked at $5.43K in Q4 2024. 78 funds tracked by Wall St. Rank hold DMAC as of Q3 2025.

Legend Financial Advisors reported no remaining DiaMedica Therapeutics position as of Q3 2025 after selling out during the quarter.
Legend Financial Advisors sold 1,000 DiaMedica Therapeutics shares in Q3 2025, an estimated $3.9K.
Legend Financial Advisors first reported a position in DiaMedica Therapeutics in Q3 2022 and held it in 11 quarters.
Legend Financial Advisors's DiaMedica Therapeutics position peaked at $5.43K in Q4 2024.
78 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2025.

Based on Legend Financial Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.